Aortic stenosis patients with moderate risk to open-heart surgery can now choose TAVR instead
The Food and Drug Administration expands the indication for Edwards Lifesciences' Sapien 3 valve allowing the transcatheter aortic valve replacement procedure to aortic stenosis patients who have intermediate risk of undergoing open-heart surgery.